Goll A, Glossmann H, Mannhold R
Naunyn Schmiedebergs Arch Pharmacol. 1986 Nov;334(3):303-12. doi: 10.1007/BF00508786.
Partially purified plasma membranes were prepared from cat ventricle. The purification factors for the calcium channel ligands (+)-3H-PN 200-110, 3H-nimodipine (1,4-dihydropyridines) and (-)-3-H-desmethoxyverapamil (a phenylalkylamine) were 3.1-, 3.4- and 2.9-fold, respectively, whilst beta-adrenoceptors labelled with (-)-3H-dihydroalprenolol were purified 3.0-fold. (+)-3H-PN 200-110 bound to 930 +/- 140 fmol/mg of membrane protein with a dissociation constant of 70 pmol/l at 25 degrees C. Under the same conditions 3H-nimodipine bound to 490 +/- 24 fmol/mg of sites with a KD of 120 pmol/l. (-)-3-H-desmethoxyverapamil bound to 530 +/- 55 fmol/mg of sites with a KD of 2.47 nmol/l. Twelve 1,4-dihydropyridines were evaluated for binding inhibition constants (Ki) with (+)-3H-PN 200-110 and 13 phenylalkylamines with (-)-3-H-desmethoxyverapamil in radioligand binding assays. Of the twelve 1,4-dihydropyridines evaluated (+/-)-nitrendipine was the most potent with a Ki-value of 280 pmol/l, nifedipine had a Ki-value of 500 pmol/l and the weakest drug tested, (+/-)-Bay b 4328, had a Ki-value of 14.3 nmol/l. The EC50-values of the same 1,4-dihydropyridines to inhibit the electrically driven cat papillary muscle were 77- to 3,450-fold higher and little correlation existed between Ki and EC50-values. Thirteen phenylalkylamines were tested for their potency to inhibit (-)-3-H-desmethoxyverapamil binding. The most potent phenylalkylamine with respect to negative inotropy was (+/-)-D 595 with an EC50-value of 794 nmol/l, the least potent substance was (+/-)-Sz 45 with an EC50-value of 39.8 mumol/l. The binding inhibition constants for the phenylalkylamines were 13- to 322-fold lower than the values for negative inotropy, but a significant positive correlation between the Ki and EC50-values (n = 12, r = 0.84) was observed. The absolute differences may reflect the state-dependent binding of phenylalkylamines to the channel. QSAR analysis revealed nearly identical correlations between physicochemical substituent properties on the one hand and binding affinities or functional potency on the other hand. In both cases the electronic properties (F-constant) of ring substituents mainly determine the variance in potency.
从猫心室制备了部分纯化的质膜。钙通道配体(+)-3H-PN 200-110、3H-尼莫地平(1,4-二氢吡啶)和(-)-3-H-去甲氧基维拉帕米(一种苯烷基胺)的纯化因子分别为3.1倍、3.4倍和2.9倍,而用(-)-3H-二氢阿普洛尔标记的β-肾上腺素受体纯化了3.0倍。(+)-3H-PN 200-110在25℃下以70 pmol/L的解离常数与930±140 fmol/mg的膜蛋白结合。在相同条件下,3H-尼莫地平以120 pmol/L的KD与490±24 fmol/mg的位点结合。(-)-3-H-去甲氧基维拉帕米以2.47 nmol/L的KD与530±55 fmol/mg的位点结合。在放射性配体结合试验中,评估了12种1,4-二氢吡啶与(+)-3H-PN 200-110的结合抑制常数(Ki)以及13种苯烷基胺与(-)-3-H-去甲氧基维拉帕米的结合抑制常数。在所评估的12种1,4-二氢吡啶中,(±)-尼群地平最有效,Ki值为280 pmol/L,硝苯地平的Ki值为500 pmol/L,测试的最弱药物(±)-Bay b 4328的Ki值为14.3 nmol/L。相同的1,4-二氢吡啶抑制电驱动猫乳头肌的EC50值高77至3450倍,且Ki与EC50值之间几乎没有相关性。测试了13种苯烷基胺抑制(-)-3-H-去甲氧基维拉帕米结合的效力。对负性肌力作用最有效的苯烷基胺是(±)-D 595,EC50值为794 nmol/L,效力最低的物质是(±)-Sz 45,EC50值为39.8 μmol/L。苯烷基胺的结合抑制常数比负性肌力作用的值低13至322倍,但观察到Ki与EC50值之间存在显著正相关(n = 12,r = 0.84)。绝对差异可能反映了苯烷基胺与通道的状态依赖性结合。定量构效关系分析表明,一方面物理化学取代基性质与另一方面结合亲和力或功能效力之间存在几乎相同的相关性。在这两种情况下,环取代基的电子性质(F常数)主要决定了效力的差异。